{
    "hands_on_practices": [
        {
            "introduction": "To evaluate the effectiveness of any tele-ophthalmology screening model, we must begin with its fundamental diagnostic accuracy. This first practice grounds you in the essential metrics of sensitivity and specificity, which quantify a model's ability to correctly identify individuals with and without disease. By constructing a classification table and applying these core definitions, you will gain a foundational skill for interpreting and critiquing the performance of any new screening technology .",
            "id": "4729670",
            "problem": "A neonatal intensive care unit deploys a tele-retinopathy of prematurity (tele-ROP) screening model in which wide-field retinal images are acquired by trained staff and graded remotely, with bedside binocular indirect ophthalmoscopy by a pediatric ophthalmologist serving as the reference standard. Over a validation cohort of $200$ infants, the reference standard identifies $30$ infants with treatment-requiring retinopathy of prematurity. The tele-ROP model flags $26$ of those $30$ infants as positive, and additionally flags $10$ infants without treatment-requiring disease as positive. Using the fundamental definitions of diagnostic test sensitivity and specificity grounded in the two-by-two classification of test results versus disease status, derive from first principles the sensitivity and specificity of the tele-ROP model for detecting treatment-requiring retinopathy of prematurity. Express both sensitivity and specificity as decimals, rounding each to four significant figures. Then, based only on these values and the implied counts of false negatives and false positives, provide a concise interpretation regarding clinical adequacy for safety-first triage in tele-ophthalmology models. The final numerical answer must consist solely of the two decimals in the order $\\text{sensitivity}$ and $\\text{specificity}$.",
            "solution": "To determine the sensitivity and specificity of the tele-ROP screening model, we first organize the provided data into a $2 \\times 2$ contingency table. This table classifies the outcomes of the screening test against the true disease status as determined by the reference standard.\n\nThe four categories in the table are:\n- True Positives ($TP$): Infants with the disease who test positive.\n- False Positives ($FP$): Infants without the disease who test positive.\n- False Negatives ($FN$): Infants with the disease who test negative.\n- True Negatives ($TN$): Infants without the disease who test negative.\n\nFrom the problem statement, we extract the following givens:\n- Total number of infants in the cohort, $N = 200$.\n- Total number of infants with treatment-requiring ROP (disease present), $D^+ = TP + FN = 30$.\n- From this, the total number of infants without treatment-requiring ROP (disease absent) is $D^- = N - D^+ = 200 - 30 = 170$. Thus, $FP + TN = 170$.\n- The model flags $26$ of the $30$ diseased infants as positive. This is the definition of True Positives, so $TP = 26$.\n- The model flags $10$ infants without the disease as positive. This is the definition of False Positives, so $FP = 10$.\n\nWith these values, we can deduce the counts for the remaining categories:\n- The number of False Negatives ($FN$) is the number of diseased infants who were not flagged as positive: $FN = D^+ - TP = 30 - 26 = 4$.\n- The number of True Negatives ($TN$) is the number of non-diseased infants who were not flagged as positive (i.e., who tested negative): $TN = D^- - FP = 170 - 10 = 160$.\n\nThe completed contingency table is as follows:\n\n|                    | Disease Present (ROP+) | Disease Absent (ROP-) | Total |\n| ------------------ | ---------------------- | --------------------- | ----- |\n| **Test Positive**  | $TP = 26$              | $FP = 10$             | $36$  |\n| **Test Negative**  | $FN = 4$               | $TN = 160$            | $164$ |\n| **Total**          | $30$                   | $170$                 | $200$ |\n\nNow, we apply the fundamental definitions of sensitivity and specificity.\n\nSensitivity, also known as the true positive rate, is the proportion of individuals with the disease who are correctly identified by the test. The formula is:\n$$ \\text{Sensitivity} = \\frac{TP}{TP + FN} $$\nSubstituting the values from our table:\n$$ \\text{Sensitivity} = \\frac{26}{26 + 4} = \\frac{26}{30} = 0.86666... $$\nRounding to four significant figures, the sensitivity is $0.8667$.\n\nSpecificity, also known as the true negative rate, is the proportion of individuals without the disease who are correctly identified by the test. The formula is:\n$$ \\text{Specificity} = \\frac{TN}{TN + FP} $$\nSubstituting the values from our table:\n$$ \\text{Specificity} = \\frac{160}{160 + 10} = \\frac{160}{170} = \\frac{16}{17} \\approx 0.941176... $$\nRounding to four significant figures, the specificity is $0.9412$.\n\nFor the interpretation regarding clinical adequacy for safety-first triage: A \"safety-first\" triage model prioritizes minimizing false negatives to ensure that no individual with the condition is missed. The sensitivity of $0.8667$ indicates that the model correctly identifies approximately $87\\%$ of infants with treatment-requiring ROP. However, this corresponds to a false negative count of $FN=4$. In a high-stakes clinical context like ROP, where missed cases can lead to permanent vision loss, any false negative is a significant safety failure. A screening test intended for safe triage is ideally expected to have a sensitivity approaching $1.00$ (or $100\\%$). The presence of $4$ missed cases raises serious concerns about the model's adequacy for this purpose. Conversely, the specificity of $0.9412$ is high, indicating that the test correctly rules out the disease in $94\\%$ of healthy infants. This minimizes the number of false positives ($FP=10$), thereby reducing the burden of unnecessary, costly, and potentially stressful follow-up examinations. While high specificity is desirable for efficiency, the non-trivial number of false negatives compromises the primary \"safety-first\" objective.",
            "answer": "$$\\boxed{\\begin{pmatrix} 0.8667 & 0.9412 \\end{pmatrix}}$$"
        },
        {
            "introduction": "While sensitivity and specificity are vital, they do not fully capture a model's practical utility in a clinical workflow. This next exercise introduces Decision Curve Analysis (DCA), a sophisticated method that assesses the net benefit of using a model for making clinical decisions, such as whether to refer a patient for further examination . You will learn to compute a model's net benefit by explicitly weighing the value of detecting true disease against the cost of unnecessary interventions for false positives, providing a more nuanced and clinically relevant measure of performance.",
            "id": "4729685",
            "problem": "A regional health system deploys a store-and-forward tele-ophthalmology screening service for referable diabetic retinopathy, in which images acquired at primary clinics are graded asynchronously by a combined Artificial Intelligence (AI) and human-reader triage model. To support referral decisions in this telemedicine pathway, the clinical leadership adopts the decision-theoretic construct of a threshold probability, denoted by $p_t$, interpreted as the minimum predicted probability of referable disease at which the expected harm of referral is balanced by the expected harm of deferring referral. The program evaluates a monthly screening cohort of size $N = 1000$. After adjudication against a masked reference standard, the triage model yields $TP = 100$ true positives and $FP = 50$ false positives at the operating point corresponding to a threshold probability $p_t = 0.1$.\n\nUsing the formal definition that net benefit in Decision Curve Analysis (DCA) aggregates clinical outcomes as the per-capita number of true positives after penalizing false positives in proportion to the odds implied by the decision threshold, compute the model’s net benefit at the specified threshold and cohort. Then, briefly interpret the clinical utility of this net benefit in the context of the tele-ophthalmology referral pathway.\n\nExpress the final net benefit as an exact fraction (unitless). No rounding is required. The final answer must be a single number without any units.",
            "solution": "The first step is to translate the provided definition of Net Benefit (NB) into a mathematical formula. The problem defines net benefit as \"the per-capita number of true positives after penalizing false positives in proportion to the odds implied by the decision threshold.\"\n\nLet $N$ be the total number of patients in the cohort.\nThe per-capita number of true positives is the total number of true positives, $TP$, divided by the cohort size, $N$:\n$$ \\text{Benefit} = \\frac{TP}{N} $$\nThe penalty is applied to the false positives. The per-capita number of false positives is $\\frac{FP}{N}$. This term is weighted by a penalty factor derived from the decision threshold, $p_t$. The problem specifies this weighting is \"in proportion to the odds implied by the decision threshold.\" The odds for a given probability $p$ are defined as $\\frac{p}{1-p}$.\nTherefore, the penalty weight for each false positive, based on the threshold probability $p_t$, is:\n$$ \\text{Weight} = \\frac{p_t}{1-p_t} $$\nThe total penalty, on a per-capita basis, is the per-capita false positives multiplied by this weight:\n$$ \\text{Harm} = \\frac{FP}{N} \\times \\left( \\frac{p_t}{1-p_t} \\right) $$\nThe Net Benefit is the benefit minus the harm:\n$$ NB(p_t) = \\frac{TP}{N} - \\frac{FP}{N} \\left( \\frac{p_t}{1-p_t} \\right) $$\nThis is the standard formula for net benefit in Decision Curve Analysis.\n\nThe problem provides the following values:\n-   Cohort size, $N = 1000$.\n-   True positives, $TP = 100$.\n-   False positives, $FP = 50$.\n-   Decision threshold probability, $p_t = 0.1$.\n\nFirst, we calculate the odds term corresponding to the threshold probability $p_t = 0.1$:\n$$ \\frac{p_t}{1-p_t} = \\frac{0.1}{1 - 0.1} = \\frac{0.1}{0.9} = \\frac{1}{9} $$\nNow, we substitute all the given values into the net benefit formula:\n$$ NB = \\frac{100}{1000} - \\frac{50}{1000} \\left( \\frac{1}{9} \\right) $$\nSimplify the fractions:\n$$ NB = \\frac{1}{10} - \\frac{1}{20} \\left( \\frac{1}{9} \\right) $$\nPerform the multiplication for the penalty term:\n$$ NB = \\frac{1}{10} - \\frac{1}{180} $$\nTo subtract the fractions, we find a common denominator, which is $180$.\n$$ NB = \\frac{1 \\times 18}{10 \\times 18} - \\frac{1}{180} = \\frac{18}{180} - \\frac{1}{180} $$\n$$ NB = \\frac{18 - 1}{180} = \\frac{17}{180} $$\nThe net benefit of the triage model at the specified threshold is $\\frac{17}{180}$.\n\n### Interpretation of Clinical Utility\n\nThe net benefit value of $\\frac{17}{180}$ quantifies the clinical utility of the tele-ophthalmology referral model at the specified threshold of $p_t=0.1$. In Decision Curve Analysis, any positive net benefit indicates that the model is superior to the default strategy of referring no one (which has a net benefit of $0$). The calculated value, approximately $0.0944$, signifies that for every $180$ patients screened using this triage model, the net clinical gain is equivalent to correctly identifying and referring $17$ patients with referable diabetic retinopathy who would have otherwise been missed (e.g., under a \"refer none\" policy), after accounting for the clinical cost of referring patients who do not have the disease (the false positives). Expressed per $100$ patients, this is a net gain equivalent to correctly referring approximately $9.44$ true cases without incurring any harm from false referrals. This positive and non-trivial value provides a quantitative justification for the clinical implementation of this model in the referral pathway, as it demonstrates a clear advantage over inaction at the given harm-benefit ratio defined by $p_t = 0.1$.",
            "answer": "$$\\boxed{\\frac{17}{180}}$$"
        },
        {
            "introduction": "Effective screening programs must demonstrate not only immediate accuracy but also a meaningful long-term impact on patient outcomes. This final practice moves from static evaluation to dynamic modeling, using a discrete-time Markov chain to simulate the progression of diabetic retinopathy over a multi-year horizon . By comparing scenarios with and without a tele-screening intervention, you will quantify the ultimate public health value of the model by estimating the number of adverse outcomes, like blindness, that can be prevented.",
            "id": "4729671",
            "problem": "Consider a cohort-based discrete-time Markov chain for diabetic retinopathy disease progression in a tele-ophthalmology context. The goal is to construct, from core probabilistic definitions, a mathematically rigorous model that compares disease evolution with and without tele-screening over a fixed horizon and quantifies expected blindness cases avoided. Use the following scientific base: a time-homogeneous Markov chain with a finite state space, probability conservation in each transition row, and the Chapman–Kolmogorov equation.\n\nDefine the state space as five mutually exclusive and collectively exhaustive states ordered as:\n- $S_0$: No diabetic retinopathy,\n- $S_1$: Mild Non-Proliferative Diabetic Retinopathy (NPDR),\n- $S_2$: Moderate Non-Proliferative Diabetic Retinopathy (NPDR),\n- $S_3$: Severe Non-Proliferative or Proliferative Diabetic Retinopathy (NPDR/PDR),\n- $S_4$: Blindness (absorbing).\n\nAssume each annual transition is governed by a row-stochastic matrix $P \\in \\mathbb{R}^{5 \\times 5}$, where each row sums to $1$, and the blindness state $S_4$ is absorbing with $P_{44} = 1$. Let the initial cohort distribution be a row vector $v_0 \\in \\mathbb{R}^{1 \\times 5}$ summing to $1$. Under a time-homogeneous Markov chain, the $n$-year distribution is $v_n = v_0 P^n$. The expected proportion blind at year $n$ is the component corresponding to $S_4$ in $v_n$. The expected number of blindness cases in a cohort of size $N$ at year $n$ is $N \\cdot v_n[4]$.\n\nYour task is to:\n- Derive the above Markov model from first principles (probability conservation, state transitions, absorbing states, and the Chapman–Kolmogorov equation), and then implement a program that, for each test case below, computes the expected number of blindness cases avoided at year $n = 5$ by tele-screening, defined as the difference between expected blindness under the no-tele-screening transition matrix and the with-tele-screening transition matrix, multiplied by the cohort size $N$.\n- Express the final results as floats, rounded to $2$ decimal places, in units of cases (counts), aggregated per test case into a single output line.\n- Angles are not involved; do not include any angle units. Percentages must be provided and handled as decimals only.\n\nFor all computations:\n- Use $n = 5$ years.\n- For each test case, use the provided initial distribution $v_0$, cohort size $N$, and two transition matrices $P_{\\text{no-tele}}$ and $P_{\\text{tele}}$.\n\nTest Suite:\n\nCase $\\mathrm{A}$ (moderate tele-screening effectiveness):\n- $v_0 = [\\,0.60,\\,0.25,\\,0.10,\\,0.05,\\,0.00\\,]$,\n- $N = 10000$,\n- $\nP_{\\text{no-tele}} =\n\\begin{pmatrix}\n0.92 & 0.08 & 0.00 & 0.00 & 0.00 \\\\\n0.05 & 0.75 & 0.18 & 0.02 & 0.00 \\\\\n0.00 & 0.07 & 0.70 & 0.20 & 0.03 \\\\\n0.00 & 0.00 & 0.05 & 0.75 & 0.20 \\\\\n0.00 & 0.00 & 0.00 & 0.00 & 1.00\n\\end{pmatrix}\n$,\n- $\nP_{\\text{tele}} =\n\\begin{pmatrix}\n0.94 & 0.06 & 0.00 & 0.00 & 0.00 \\\\\n0.10 & 0.78 & 0.10 & 0.02 & 0.00 \\\\\n0.00 & 0.12 & 0.68 & 0.18 & 0.02 \\\\\n0.00 & 0.00 & 0.12 & 0.76 & 0.12 \\\\\n0.00 & 0.00 & 0.00 & 0.00 & 1.00\n\\end{pmatrix}\n$.\n\nCase $\\mathrm{B}$ (no tele-screening effect; identical transitions):\n- $v_0 = [\\,0.60,\\,0.25,\\,0.10,\\,0.05,\\,0.00\\,]$,\n- $N = 10000$,\n- $\nP_{\\text{no-tele}} =\n\\begin{pmatrix}\n0.92 & 0.08 & 0.00 & 0.00 & 0.00 \\\\\n0.05 & 0.75 & 0.18 & 0.02 & 0.00 \\\\\n0.00 & 0.07 & 0.70 & 0.20 & 0.03 \\\\\n0.00 & 0.00 & 0.05 & 0.75 & 0.20 \\\\\n0.00 & 0.00 & 0.00 & 0.00 & 1.00\n\\end{pmatrix}\n$,\n- $\nP_{\\text{tele}} =\n\\begin{pmatrix}\n0.92 & 0.08 & 0.00 & 0.00 & 0.00 \\\\\n0.05 & 0.75 & 0.18 & 0.02 & 0.00 \\\\\n0.00 & 0.07 & 0.70 & 0.20 & 0.03 \\\\\n0.00 & 0.00 & 0.05 & 0.75 & 0.20 \\\\\n0.00 & 0.00 & 0.00 & 0.00 & 1.00\n\\end{pmatrix}\n$.\n\nCase $\\mathrm{C}$ (strong tele-screening effectiveness with some pre-existing blindness):\n- $v_0 = [\\,0.50,\\,0.30,\\,0.15,\\,0.04,\\,0.01\\,]$,\n- $N = 20000$,\n- $\nP_{\\text{no-tele}} =\n\\begin{pmatrix}\n0.92 & 0.08 & 0.00 & 0.00 & 0.00 \\\\\n0.05 & 0.75 & 0.18 & 0.02 & 0.00 \\\\\n0.00 & 0.07 & 0.70 & 0.20 & 0.03 \\\\\n0.00 & 0.00 & 0.05 & 0.75 & 0.20 \\\\\n0.00 & 0.00 & 0.00 & 0.00 & 1.00\n\\end{pmatrix}\n$,\n- $\nP_{\\text{tele}} =\n\\begin{pmatrix}\n0.95 & 0.05 & 0.00 & 0.00 & 0.00 \\\\\n0.15 & 0.78 & 0.06 & 0.01 & 0.00 \\\\\n0.00 & 0.18 & 0.70 & 0.10 & 0.02 \\\\\n0.00 & 0.00 & 0.20 & 0.72 & 0.08 \\\\\n0.00 & 0.00 & 0.00 & 0.00 & 1.00\n\\end{pmatrix}\n$.\n\nCase $\\mathrm{D}$ (boundary case: all initially blind, absorbing):\n- $v_0 = [\\,0.00,\\,0.00,\\,0.00,\\,0.00,\\,1.00\\,]$,\n- $N = 5000$,\n- $\nP_{\\text{no-tele}} =\n\\begin{pmatrix}\n0.92 & 0.08 & 0.00 & 0.00 & 0.00 \\\\\n0.05 & 0.75 & 0.18 & 0.02 & 0.00 \\\\\n0.00 & 0.07 & 0.70 & 0.20 & 0.03 \\\\\n0.00 & 0.00 & 0.05 & 0.75 & 0.20 \\\\\n0.00 & 0.00 & 0.00 & 0.00 & 1.00\n\\end{pmatrix}\n$,\n- $\nP_{\\text{tele}} =\n\\begin{pmatrix}\n0.94 & 0.06 & 0.00 & 0.00 & 0.00 \\\\\n0.10 & 0.78 & 0.10 & 0.02 & 0.00 \\\\\n0.00 & 0.12 & 0.68 & 0.18 & 0.02 \\\\\n0.00 & 0.00 & 0.12 & 0.76 & 0.12 \\\\\n0.00 & 0.00 & 0.00 & 0.00 & 1.00\n\\end{pmatrix}\n$.\n\nRequired final output format:\n- Your program should produce a single line of output containing the results as a comma-separated list enclosed in square brackets, for the four cases $\\mathrm{A}$, $\\mathrm{B}$, $\\mathrm{C}$, and $\\mathrm{D}$ in order, for example: $[r_A,r_B,r_C,r_D]$.\n- Each $r_\\cdot$ is the expected number of blindness cases avoided at year $n=5$, in cases, rounded to $2$ decimal places.",
            "solution": "Herein, we derive the discrete-time Markov chain model for disease progression from first principles and then outline the computational procedure.\n\nA discrete-time Markov chain is a stochastic model describing a sequence of events in which the probability of each event depends only on the state attained in the previous event. Let $X_n$ be a random variable representing the state of a subject at time step $n$, where $n \\in \\{0, 1, 2, \\ldots\\}$ represents the year.\n\nThe state space $S$ is the set of all possible states, which is defined as a finite, ordered set of five mutually exclusive and collectively exhaustive states of diabetic retinopathy:\n$S_0$: No diabetic retinopathy,\n$S_1$: Mild Non-Proliferative Diabetic Retinopathy (NPDR),\n$S_2$: Moderate NPDR,\n$S_3$: Severe NPDR or Proliferative Diabetic Retinopathy (PDR),\n$S_4$: Blindness.\n\nThe distribution of the cohort across these states at any time $n$ is described by a probability row vector $v_n \\in \\mathbb{R}^{1 \\times 5}$. The $j$-th component of this vector, denoted $v_n(j)$ (for $j \\in \\{0, 1, 2, 3, 4\\}$), represents the probability that a randomly selected individual from the cohort is in state $S_j$ at year $n$. Thus, $\\mathbb{P}(X_n = S_j) = v_n(j)$. By definition, the components of a probability vector must sum to unity: $\\sum_{j=0}^{4} v_n(j) = 1$. The initial distribution of the cohort at $n=0$ is given by the vector $v_0$.\n\nThe evolution of the system is governed by one-step transition probabilities. The Markov property asserts that the future state of the system depends only on its present state, not on its past history. For a time-homogeneous Markov chain, these transition probabilities are constant over time. We define the one-step transition probability $P_{ij}$ as the probability of moving from state $S_i$ to state $S_j$ in one year:\n$$P_{ij} = \\mathbb{P}(X_{n+1} = S_j | X_n = S_i)$$\nThese probabilities are organized into a $5 \\times 5$ transition matrix $P$, where the entry in the $i$-th row and $j$-th column is $P_{ij}$.\n\nA fundamental principle is probability conservation. An individual in state $S_i$ must transition to some state in the space $S$ in the next time step. Therefore, the sum of probabilities of transitioning out of state $S_i$ to any possible state $S_j$ must be $1$. This means each row of the transition matrix must sum to $1$:\n$$\\sum_{j=0}^{4} P_{ij} = 1 \\quad \\text{for all } i \\in \\{0, 1, 2, 3, 4\\}$$\nSuch a matrix is known as a row-stochastic matrix.\n\nThe state distribution at year $n+1$ can be determined from the distribution at year $n$ using the law of total probability. The probability of being in state $S_j$ at time $n+1$ is the sum of probabilities of transitioning from every possible state $S_i$ at time $n$ to state $S_j$:\n$$v_{n+1}(j) = \\mathbb{P}(X_{n+1} = S_j) = \\sum_{i=0}^{4} \\mathbb{P}(X_{n+1} = S_j \\text{ and } X_n = S_i)$$\nUsing the definition of conditional probability, this becomes:\n$$v_{n+1}(j) = \\sum_{i=0}^{4} \\mathbb{P}(X_{n+1} = S_j | X_n = S_i) \\mathbb{P}(X_n = S_i) = \\sum_{i=0}^{4} P_{ij} v_n(i)$$\nThis expression is precisely the $j$-th component of the matrix-vector product $v_n P$. Thus, the evolution of the state distribution vector is given by the recurrence relation:\n$$v_{n+1} = v_n P$$\nBy applying this relation iteratively, we find the distribution at year $n$:\n$$v_n = v_{n-1} P = (v_{n-2} P) P = \\dots = v_0 P^n$$\nThis equation is a direct consequence of the Chapman-Kolmogorov equation, which states that the $n$-step transition matrix is the $n$-th power of the one-step transition matrix.\n\nThe state $S_4$ (Blindness) is defined as an absorbing state. An absorbing state $S_j$ is one from which it is impossible to leave. This is mathematically expressed as $P_{jj} = 1$ and $P_{jk} = 0$ for all $k \\neq j$. For our model, this means the last row of the transition matrix $P$ is $[0, 0, 0, 0, 1]$.\n\nThe proportion of the cohort that is expected to be in the blindness state $S_4$ at year $n$ is given by the 5th component of the state vector $v_n$. Using $0$-based indexing, this is $v_n[4]$. For a cohort of size $N$, the expected number of individuals who are blind at year $n$ is:\n$$E[\\text{Blindness at year } n] = N \\cdot v_n[4] = N \\cdot (v_0 P^n)[4]$$\nThe problem requires comparing two scenarios: one without tele-screening, governed by matrix $P_{\\text{no-tele}}$, and one with tele-screening, governed by matrix $P_{\\text{tele}}$. The expected number of blindness cases for each scenario at year $n$ is:\n$$E_{\\text{no-tele}}(n) = N \\cdot (v_0 P_{\\text{no-tele}}^n)[4]$$\n$$E_{\\text{tele}}(n) = N \\cdot (v_0 P_{\\text{tele}}^n)[4]$$\nThe goal is to compute the expected number of blindness cases avoided due to tele-screening at the time horizon $n=5$. This is the difference between the expected number of cases in the two scenarios:\n$$\\Delta E(5) = E_{\\text{no-tele}}(5) - E_{\\text{tele}}(5) = N \\left( (v_0 P_{\\text{no-tele}}^5)[4] - (v_0 P_{\\text{tele}}^5)[4] \\right)$$\nThe computational procedure for each test case is as follows:\n1. Take the provided initial distribution $v_0$, cohort size $N$, and the two transition matrices $P_{\\text{no-tele}}$ and $P_{\\text{tele}}$.\n2. Compute the 5th power of each transition matrix: $P_{\\text{no-tele}}^5$ and $P_{\\text{tele}}^5$.\n3. Compute the state distribution vector at $n=5$ for each scenario: $v_{5, \\text{no-tele}} = v_0 P_{\\text{no-tele}}^5$ and $v_{5, \\text{tele}} = v_0 P_{\\text{tele}}^5$.\n4. Extract the 5th component (index $4$) from each resulting vector, which corresponds to the proportion of the cohort in state $S_4$.\n5. Calculate the difference in these proportions and multiply by the cohort size $N$ to find the expected number of cases avoided.\n6. Round the final result to two decimal places.",
            "answer": "```python\n# The complete and runnable Python 3 code goes here.\n# Imports must adhere to the specified execution environment.\nimport numpy as np\n\ndef solve():\n    \"\"\"\n    Computes the expected number of blindness cases avoided by tele-screening\n    for several test cases using a discrete-time Markov chain model.\n    \"\"\"\n    test_cases = [\n        # Case A: moderate tele-screening effectiveness\n        {\n            \"v0\": np.array([0.60, 0.25, 0.10, 0.05, 0.00]),\n            \"N\": 10000,\n            \"P_no_tele\": np.array([\n                [0.92, 0.08, 0.00, 0.00, 0.00],\n                [0.05, 0.75, 0.18, 0.02, 0.00],\n                [0.00, 0.07, 0.70, 0.20, 0.03],\n                [0.00, 0.00, 0.05, 0.75, 0.20],\n                [0.00, 0.00, 0.00, 0.00, 1.00]\n            ]),\n            \"P_tele\": np.array([\n                [0.94, 0.06, 0.00, 0.00, 0.00],\n                [0.10, 0.78, 0.10, 0.02, 0.00],\n                [0.00, 0.12, 0.68, 0.18, 0.02],\n                [0.00, 0.00, 0.12, 0.76, 0.12],\n                [0.00, 0.00, 0.00, 0.00, 1.00]\n            ])\n        },\n        # Case B: no tele-screening effect\n        {\n            \"v0\": np.array([0.60, 0.25, 0.10, 0.05, 0.00]),\n            \"N\": 10000,\n            \"P_no_tele\": np.array([\n                [0.92, 0.08, 0.00, 0.00, 0.00],\n                [0.05, 0.75, 0.18, 0.02, 0.00],\n                [0.00, 0.07, 0.70, 0.20, 0.03],\n                [0.00, 0.00, 0.05, 0.75, 0.20],\n                [0.00, 0.00, 0.00, 0.00, 1.00]\n            ]),\n            \"P_tele\": np.array([\n                [0.92, 0.08, 0.00, 0.00, 0.00],\n                [0.05, 0.75, 0.18, 0.02, 0.00],\n                [0.00, 0.07, 0.70, 0.20, 0.03],\n                [0.00, 0.00, 0.05, 0.75, 0.20],\n                [0.00, 0.00, 0.00, 0.00, 1.00]\n            ])\n        },\n        # Case C: strong tele-screening effectiveness\n        {\n            \"v0\": np.array([0.50, 0.30, 0.15, 0.04, 0.01]),\n            \"N\": 20000,\n            \"P_no_tele\": np.array([\n                [0.92, 0.08, 0.00, 0.00, 0.00],\n                [0.05, 0.75, 0.18, 0.02, 0.00],\n                [0.00, 0.07, 0.70, 0.20, 0.03],\n                [0.00, 0.00, 0.05, 0.75, 0.20],\n                [0.00, 0.00, 0.00, 0.00, 1.00]\n            ]),\n            \"P_tele\": np.array([\n                [0.95, 0.05, 0.00, 0.00, 0.00],\n                [0.15, 0.78, 0.06, 0.01, 0.00],\n                [0.00, 0.18, 0.70, 0.10, 0.02],\n                [0.00, 0.00, 0.20, 0.72, 0.08],\n                [0.00, 0.00, 0.00, 0.00, 1.00]\n            ])\n        },\n        # Case D: boundary case, all initially blind\n        {\n            \"v0\": np.array([0.00, 0.00, 0.00, 0.00, 1.00]),\n            \"N\": 5000,\n            \"P_no_tele\": np.array([\n                [0.92, 0.08, 0.00, 0.00, 0.00],\n                [0.05, 0.75, 0.18, 0.02, 0.00],\n                [0.00, 0.07, 0.70, 0.20, 0.03],\n                [0.00, 0.00, 0.05, 0.75, 0.20],\n                [0.00, 0.00, 0.00, 0.00, 1.00]\n            ]),\n            \"P_tele\": np.array([\n                [0.94, 0.06, 0.00, 0.00, 0.00],\n                [0.10, 0.78, 0.10, 0.02, 0.00],\n                [0.00, 0.12, 0.68, 0.18, 0.02],\n                [0.00, 0.00, 0.12, 0.76, 0.12],\n                [0.00, 0.00, 0.00, 0.00, 1.00]\n            ])\n        }\n    ]\n\n    results = []\n    n = 5  # Time horizon in years\n    blindness_state_index = 4\n\n    for case in test_cases:\n        v0 = case[\"v0\"]\n        N = case[\"N\"]\n        P_no_tele = case[\"P_no_tele\"]\n        P_tele = case[\"P_tele\"]\n\n        # Calculate the n-step transition matrices\n        P_no_tele_n = np.linalg.matrix_power(P_no_tele, n)\n        P_tele_n = np.linalg.matrix_power(P_tele, n)\n\n        # Calculate the state distribution vector at year n for each scenario\n        v_n_no_tele = v0 @ P_no_tele_n\n        v_n_tele = v0 @ P_tele_n\n\n        # Get the proportion of the cohort in the blindness state\n        prop_blind_no_tele = v_n_no_tele[blindness_state_index]\n        prop_blind_tele = v_n_tele[blindness_state_index]\n\n        # Calculate the expected number of blindness cases for each scenario\n        expected_blind_no_tele = N * prop_blind_no_tele\n        expected_blind_tele = N * prop_blind_tele\n\n        # Calculate the expected number of blindness cases avoided\n        cases_avoided = expected_blind_no_tele - expected_blind_tele\n        \n        results.append(cases_avoided)\n\n    # Format results to 2 decimal places and create the output string\n    formatted_results = [f\"{res:.2f}\" for res in results]\n    print(f\"[{','.join(formatted_results)}]\")\n\nsolve()\n```"
        }
    ]
}